Conjunctivitis, Bacterial [clinicaltrials_resource:86c42250b9aae6a128465eddb216e72f]
clinicaltrials:NCT00105469clinicaltrials:NCT00105534clinicaltrials:NCT00312338AL-15469A for the Treatment of Bacterial Conjunctivitis [clinicaltrials:NCT00331916]AL-15469A for the Treatment of Bacterial Conjunctivitis [clinicaltrials:NCT00332293]clinicaltrials:NCT00347932clinicaltrials:NCT00348348Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis [clinicaltrials:NCT00357773]Systemic Pharmacokinetics of BOL-303224-A [clinicaltrials:NCT00407589]clinicaltrials:NCT00464438clinicaltrials:NCT00509873clinicaltrials:NCT00518089Study of Efficacy of Levofloxacin 0.5% Ophthalmic Solution Administered Three Times a Day for Bacterial Conjunctivitis [clinicaltrials:NCT00565123]clinicaltrials:NCT00622908clinicaltrials:NCT00759148clinicaltrials:NCT00798577clinicaltrials:NCT00972777Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children. [clinicaltrials:NCT01155999]clinicaltrials:NCT01175590Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis [clinicaltrials:NCT01227863]Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis [clinicaltrials:NCT01227915]Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis [clinicaltrials:NCT01238783]clinicaltrials:NCT01330355clinicaltrials:NCT01573910clinicaltrials:NCT01721694clinicaltrials:NCT01740388clinicaltrials:NCT01877694Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis [clinicaltrials:NCT02432807]
condition browse [clinicaltrials_vocabulary:condition-browse]
clinicaltrials:NCT00105469clinicaltrials:NCT00105534clinicaltrials:NCT00312338AL-15469A for the Treatment of Bacterial Conjunctivitis [clinicaltrials:NCT00331916]AL-15469A for the Treatment of Bacterial Conjunctivitis [clinicaltrials:NCT00332293]clinicaltrials:NCT00347932clinicaltrials:NCT00348348Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis [clinicaltrials:NCT00357773]Systemic Pharmacokinetics of BOL-303224-A [clinicaltrials:NCT00407589]clinicaltrials:NCT00464438clinicaltrials:NCT00509873clinicaltrials:NCT00518089Study of Efficacy of Levofloxacin 0.5% Ophthalmic Solution Administered Three Times a Day for Bacterial Conjunctivitis [clinicaltrials:NCT00565123]clinicaltrials:NCT00622908clinicaltrials:NCT00759148clinicaltrials:NCT00798577clinicaltrials:NCT00972777Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children. [clinicaltrials:NCT01155999]clinicaltrials:NCT01175590Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis [clinicaltrials:NCT01227863]Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis [clinicaltrials:NCT01227915]Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis [clinicaltrials:NCT01238783]clinicaltrials:NCT01330355clinicaltrials:NCT01573910clinicaltrials:NCT01721694clinicaltrials:NCT01740388clinicaltrials:NCT01877694Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis [clinicaltrials:NCT02432807]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Conjunctivitis, Bacterial [clinicaltrials_resource:86c42250b9aae6a128465eddb216e72f]
Bio2RDF identifier
86c42250b9aae6a128465eddb216e72f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:86c42250b9aae6a128465eddb216e72f
identifier
clinicaltrials_resource:86c42250b9aae6a128465eddb216e72f
title
Conjunctivitis, Bacterial
@en
type
label
Conjunctivitis, Bacterial [clinicaltrials_resource:86c42250b9aae6a128465eddb216e72f]
@en
Conjunctivitis, Bacterial